Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Copper Quest To Acquire 100% Interest in the...

Crypto Market Update: Binance Eyes US Re-entry After...

Dr. Mark Thornton: Gold Ringing Alarm Bells, Silver...

Nickel Price Update: Q3 2025 in Review

Apex Resources: Strategic Critical Minerals Assets in North...

Apollo Silver Closes $26.78 Million Private Placement Offering